• Episode 40: Black Lab X and Me Biosciences: Jean-Paul O'Brien's Vision of the Future

  • Jan 8 2025
  • Length: 1 hr and 1 min
  • Podcast

Episode 40: Black Lab X and Me Biosciences: Jean-Paul O'Brien's Vision of the Future

  • Summary

  • In this episode, Jean-Paul O’Brien, founder of Black Lab X and CEO of Me Biosciences, shares his transformative journey from software innovation to addressing personal health challenges that ignited his passion for genomics and AI. With a mission to unlock human potential and positively impact a billion lives by 2030, Jean-Paul explores the integration of advanced technologies in healthcare, focusing on personalized strategies for well-being and performance.

    He discusses the innovative ecosystem of Black Lab X, highlighting the critical role of purpose, resilience, and systems thinking in creating meaningful change. Jean-Paul also provides a glimpse into the future of AI-native companies and their potential to revolutionize industries, especially healthcare. This episode is packed with insights, tools, and inspiration for anyone looking to optimize their life, whether you’re an entrepreneur, athlete, or simply curious about human potential.

    Episode Highlights:

    • Jean-Paul’s journey from software innovation to genomics and AI
    • The mission and vision of Black Lab X
    • The birth of Me Biosciences and personalized medicine
    • Using DNA insights to optimize athletic performance
    • The future of AI in startups and healthcare
    • Finding purpose and meaning in innovation

    Connect with JP

    Website:

    www.blacklabx.com

    www.blacklabx.com/next

    Connect on:

    Facebook


    Twitter


    Instagram



    LINKS:

    https://www.drjeremykoenig.com/
    https://www.instagram.com/drjeremykoenig/
    https://www.youtube.com/@drjeremykoenig

    Show More Show Less

What listeners say about Episode 40: Black Lab X and Me Biosciences: Jean-Paul O'Brien's Vision of the Future

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.